世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Noninvasive Ventilation Masks Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: ByProduct (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), End User (Hospitals and Clinics, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)


The noninvasive ventilation masks market size is projected to reach US$ 3.25 billion by 2031 from US$ 2.05 billion in 2023. The market is expected to register a CAGR of 5.9% during 2023–2031. ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ
2024年10月22日 US$5,190
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
176 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The noninvasive ventilation masks market size is projected to reach US$ 3.25 billion by 2031 from US$ 2.05 billion in 2023. The market is expected to register a CAGR of 5.9% during 2023–2031.

Invasive ventilation methods are often avoided in COPD patients to reduce risks of complications such as infections and mechanical lung injuries. Noninvasive ventilation masks are preferred because they provide breathing support without requiring intubation.

A NIV reusable mask is a flexible and contoured device that covers a patient's nose and mouth and connects with a continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BPAP) machine. This device supplies ambient air or a combination of medical oxygen (O2) and air at elevated pressure to the respiratory system for non-invasive positive pressure ventilation (NPPV). Various products such as PerformaTrak Reusable NIV Mask manufactured by Philips and NIV, non-vented, complete- NIV Face Mask by MSF International are commercially available NIV masks that can be reused during NIV therapy. These reusable NIV masks help healthcare facilities reduce the cost of consumables and provide non-invasive and comfortable ventilation to the patients.

Additionally, Air Liquide Medical Systems, a subsidiary of Air Liquide Healthcare operating in the noninvasive ventilation masks market, launched its ALNEST N1 Silent mask in May 2023. This product is integrated with Quiet Flow leak to ensure an optimal noise level and gent diffusion of the exhaled air. The company’s newly launched Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices. These NIV masks are designed for home or hospital use by patients (weighing more than 30 kg) who have been prescribed NPPV, such as CPAP or BiPAP therapy. The launch of products with advanced technology, such as Quiet Flow leak, Quiet Flow ventilation port, and innovative headgear, is expected to increase the demand for reusable NIV masks for NIV therapy.

The use of noninvasive ventilation has increased significantly and has become an integral tool in the management of acute and chronic respiratory failure in the home setting. NIV therapy in a homecare setting helps improve survival and quality of life for chronic stable hypercapnia. The patients recovering from acute respiratory failure associated with COPD are required to be evaluated for at least 2–4 weeks after resolution of respiratory acidosis. Thus, they can be provided with NIV at home. Also, stable COPD patients with chronic hypercapnic respiratory failure can benefit from home NIV. These aforementioned benefits drive the demand for NIV masks in home care settings.

The need for personalized NIV masks is widely recognized, and potential strategies are focused on the long-term use of these masks in patients in home settings. In March 2024, researchers from Imperial College London and Sheffield Children's Hospital received funding from children’s charity Action Medical Research and LifeArc, a charitable medical research organization, to develop a fully automated approach to creating customized NIV masks for children. This project will be carried out in partnership with companies such as Photocentric and Polymetrix. Such initiatives by research organizations are likely to bring opportunities for market players to attract new customers.

End User-Based Insights

Based on end user, the noninvasive ventilation masks market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment held the largest share in the noninvasive ventilation masks market in 2023 and is expected to register the highest CAGR in the market during 2023–2031. There has been an increase in medical costs over the last few decades with developments in healthcare technology. Development in hospital technologies, reforms in health insurance policies, economic growth of various regions, improved reimbursement programs, and various products and services provided are among the major reasons fueling the noninvasive ventilation masks market growth for the hospital and clinics segment. The growing number of hospitalizations due to increasing incidences of diseases such as asthma, COPD, and other chronic respiratory disorders, and the worldwide presence of hospitals such as Harefield Hospital, SingHealth Group of hospitals, and the Royal Gwent Hospital that provide NIV services also drive the market growth for the segment. The Royal Gwent Hospital, Newport, UK, has been providing NIV retrieval services (NRS) since 2017 with the aim of facilitating optimal management of patients requiring NIV therapy.

United Nation Department of Economic and Social Affairs, World Health Organization, Centers for Diseases Control and Prevention, Food and Drug Administration, and European Center for Disease Prevention and Control are among the primary and secondary sources referred to while preparing the noninvasive ventilation masks market report.

ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Noninvasive Ventilation Masks Market Landscape
4.1 PEST Analysis
5. Noninvasive Ventilation Masks Market – Key Market Dynamics
5.1 Noninvasive Ventilation Masks Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Respiratory Diseases
5.2.2 Growing Inclination Toward Home Healthcare
5.3 Market Restraints
5.3.1 Side Effects Associated with NIV Masks
5.4 Market Opportunities
5.4.1 Increasing Adoption of NIV Masks
5.5 Future Trends
5.5.1 Rising Technological Advancements
5.6 Impact of Drivers and Restraints:
6. Noninvasive Ventilation Masks Market – Global Market Analysis
6.1 Noninvasive Ventilation Masks Market Revenue (US$ Million), 2021–2031
6.2 Noninvasive Ventilation Masks Market Forecast Analysis
7. Noninvasive Ventilation Masks Market Analysis – by Product
7.1 Noninvasive Ventilation Disposable Mask
7.1.1 Overview
7.1.2 Noninvasive Ventilation Disposable Mask: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Noninvasive Ventilation Reusable Mask
7.2.1 Overview
7.2.2 Noninvasive Ventilation Reusable Mask: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8. Noninvasive Ventilation Masks Market Analysis – by Application
8.1 Sleep Apnea
8.1.1 Overview
8.1.2 Sleep Apnea: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Chronic Obstructive Pulmonary Disease
8.2.1 Overview
8.2.2 Chronic Obstructive Pulmonary Disease: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Pneumonia
8.3.1 Overview
8.3.2 Pneumonia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9. Noninvasive Ventilation Masks Market Analysis – by End User
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Home Care
9.2.1 Overview
9.2.2 Home Care: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10. Noninvasive Ventilation Masks Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Noninvasive Ventilation Masks Market Overview
10.2.2 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.3.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.2.4 North America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.4.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.5.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.2.6 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 United States: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.2.2 United States: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.2.3 United States: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.6.3 Canada: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Canada: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.3.2 Canada: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.3.3 Canada: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.6.4 Mexico: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.4.1 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.4.2 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.4.3 Mexico: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Noninvasive Ventilation Masks Market Overview
10.3.2 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.3.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.3.4 Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.4.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.5.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.3.6 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.3.6.2 United Kingdom: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.2.2 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.2.3 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.3 Germany: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 Germany: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.3.2 Germany: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.3.3 Germany: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.4 France: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 France: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.4.2 France: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.4.3 France: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.5 Italy: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.5.2 Italy: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.5.3 Italy: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.6 Spain: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Spain: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.6.2 Spain: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.6.3 Spain: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.7 Rest of Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.7.2 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Noninvasive Ventilation Masks Market Overview
10.4.2 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.3.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.4.4 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.4.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.5.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.4.6 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.4.6.2 China: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 China: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.2.2 China: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.2.3 China: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.3 Japan: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 Japan: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.3.2 Japan: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.3.3 Japan: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.4 India: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 India: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.4.2 India: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.4.3 India: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.5 Australia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 Australia: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.5.2 Australia: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.5.3 Australia: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.6 South Korea: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.6.2 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.6.3 South Korea: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.7 Rest of APAC: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.7.2 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Noninvasive Ventilation Masks Market Overview
10.5.2 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.3.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.5.4 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.4.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.5.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.5.6 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.5.6.2 South Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.2.2 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.2.3 South Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.3 Saudi Arabia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.3.2 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.3.3 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.4 United Arab Emirates: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.4.2 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.5 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.5.2 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Noninvasive Ventilation Masks Market Overview
10.6.2 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.3.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.6.4 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.4.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.5.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.6.6 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.2.2 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.2.3 Brazil: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.6.3 Argentina: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.3.2 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.3.3 Argentina: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.6.4 Rest of South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.4.2 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Noninvasive Ventilation Mask Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Hamilton Medical AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ResMed Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Fisher & Paykel Healthcare Corp Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Air Liquide Medical Systems
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Dragerwerk AG & Co KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Intersurgical Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 BMC Medical Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DeVilbiss Healthcare LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Armstrong Medical Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Koninklijke Philips NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Besmed Health Business Corp
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Sleepnet Corporation.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 SunMed Group Holdings LLC ( AirLife)
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Dimar S.P.A.
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Hangzhou Formed Medical Devices Co., Ltd
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 SURU INTERNATIONAL PVT. LTD.
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 Medline Industries LP
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13. Appendix
13.1 Glossary of Terms
13.2 About The Insight Partners

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート


よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/25 10:26

155.25 円

163.23 円

198.36 円

ページTOPに戻る